132 related articles for article (PubMed ID: 21605671)
1. Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate.
Fontana MC; Rezer JF; Coradini K; Leal DB; Beck RC
Eur J Pharm Biopharm; 2011 Oct; 79(2):241-9. PubMed ID: 21605671
[TBL] [Abstract][Full Text] [Related]
2. Nanoencapsulation of Clobetasol Propionate Decreases Its Penetration to Skin Layers Without Changing Its Relative Skin Distribution.
de Andrade DF; Fontana MC; Pohlmann AR; Guterres SS; Carlos R; Beck R
J Nanosci Nanotechnol; 2015 Jan; 15(1):875-9. PubMed ID: 26328452
[TBL] [Abstract][Full Text] [Related]
3. Hydrogel containing silibinin nanocapsules presents effective anti-inflammatory action in a model of irritant contact dermatitis in mice.
Rigon C; Marchiori MCL; da Silva Jardim F; Pegoraro NS; Chaves PDS; Velho MC; Beck RCR; Ourique AF; Sari MHM; Oliveira SM; Cruz L
Eur J Pharm Sci; 2019 Sep; 137():104969. PubMed ID: 31238095
[TBL] [Abstract][Full Text] [Related]
4. Improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine.
Ourique AF; Melero A; de Bona da Silva C; Schaefer UF; Pohlmann AR; Guterres SS; Lehr CM; Kostka KH; Beck RC
Eur J Pharm Biopharm; 2011 Sep; 79(1):95-101. PubMed ID: 21402157
[TBL] [Abstract][Full Text] [Related]
5. Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study.
Marchiori ML; Lubini G; Dalla Nora G; Friedrich RB; Fontana MC; Ourique AF; Bastos MO; Rigo LA; Silva CB; Tedesco SB; Beck RC
Drug Dev Ind Pharm; 2010 Aug; 36(8):962-71. PubMed ID: 20590450
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects.
Mathes C; Melero A; Conrad P; Vogt T; Rigo L; Selzer D; Prado WA; De Rossi C; Garrigues TM; Hansen S; Guterres SS; Pohlmann AR; Beck RCR; Lehr CM; Schaefer UF
J Control Release; 2016 Feb; 223():207-214. PubMed ID: 26686081
[TBL] [Abstract][Full Text] [Related]
7. Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release, and photostability.
Fontana MC; Coradini K; Pohlmann AR; Guterres SS; Beck RC
J Nanosci Nanotechnol; 2010 May; 10(5):3091-9. PubMed ID: 20358904
[TBL] [Abstract][Full Text] [Related]
8. Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system.
Fontana MC; Coradini K; Guterres SS; Pohlmann AR; Beck RC
J Biomed Nanotechnol; 2009 Jun; 5(3):254-63. PubMed ID: 20055007
[TBL] [Abstract][Full Text] [Related]
9. Topical application of clobetasol 17-propionate from various cream bases by using Wistar rat as an animal model.
Fang JY; Shen KL; Huang YB; Wu PC; Tsai YH
Kaohsiung J Med Sci; 1998 May; 14(5):286-93. PubMed ID: 9619014
[TBL] [Abstract][Full Text] [Related]
10. Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model.
Karami H; Niavand MR; Haddadi R; Noriyan A; Vafaei SY
Int J Pharm; 2024 May; 656():124029. PubMed ID: 38527566
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery.
Şenyiğit T; Sonvico F; Rossi A; Tekmen I; Santi P; Colombo P; Nicoli S; Özer Ö
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035957
[TBL] [Abstract][Full Text] [Related]
12. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
[TBL] [Abstract][Full Text] [Related]
13. Influence of the type of vegetable oil on the drug release profile from lipid-core nanocapsules and in vivo genotoxicity study.
Rigo LA; Frescura V; Fiel L; Coradini K; Ourique AF; Emanuelli T; Quatrin A; Tedesco S; Silva CB; Guterres SS; Pohlmann AR; Beck RC
Pharm Dev Technol; 2014 Nov; 19(7):789-98. PubMed ID: 23978050
[TBL] [Abstract][Full Text] [Related]
14. Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization.
Alves PM; Pohlmann AR; Guterres SS
Pharmazie; 2005 Dec; 60(12):900-4. PubMed ID: 16398265
[TBL] [Abstract][Full Text] [Related]
15. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo--part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies.
Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A
Colloids Surf B Biointerfaces; 2014 Jul; 119():145-53. PubMed ID: 24767976
[TBL] [Abstract][Full Text] [Related]
16. An experimental model of contact dermatitis: evaluation of the oxidative profile of Wistar rats treated with free and nanoencapsulated clobetasol.
Jaques JA; Rezer JF; Ruchel JB; Souza Vdo C; Pinheiro Kde V; Schlemmer KB; Schlemmer JB; Bertoldo TM; Martins NM; Bertoncheli Cde M; Fontana MC; Beck RC; Leal DB
Redox Rep; 2012; 17(5):206-13. PubMed ID: 23068967
[TBL] [Abstract][Full Text] [Related]
17. Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System.
de Andrade DF; Zuglianello C; Pohlmann AR; Guterres SS; Beck RC
AAPS PharmSciTech; 2015 Dec; 16(6):1409-17. PubMed ID: 25986595
[TBL] [Abstract][Full Text] [Related]
18. Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice.
Bovenschen HJ; Van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):439-44. PubMed ID: 19845822
[TBL] [Abstract][Full Text] [Related]
19. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies.
Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A
Colloids Surf B Biointerfaces; 2013 Feb; 102():86-94. PubMed ID: 23000677
[TBL] [Abstract][Full Text] [Related]
20. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
